Tirzepatide 30mg / 3ml BAC Water

Tirzepatide – Research Peptide

✔ Dual GLP-1 & GIP Receptor Agonist✔ Third-Party Tested✔ Batch-Specific COA Available

🔬 Product Overview

Tirzepatide is a dual-agonist peptide designed to activate both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors.

This dual-pathway mechanism makes it a key focus in laboratory research involving metabolic regulation, appetite signaling, energy balance, and glucose metabolism.

This product is intended strictly for research and analytical purposes.

Dual-Receptor Mechanism (GLP-1 + GIP)

Tirzepatide’s defining feature is its ability to activate two metabolic pathways simultaneously.

Preclinical research suggests it may:

• Activate GLP-1 receptors associated with satiety and glucose signaling

• Activate GIP receptors linked to metabolic efficiency

• Produce synergistic metabolic effects beyond single-pathway compounds

• Support multi-pathway endocrine signaling

This positions Tirzepatide as a leading compound in dual-agonist metabolic research.

Appetite & Satiety Pathways (GLP-1)

GLP-1 signaling plays a central role in hunger and fullness regulation.

Research suggests Tirzepatide may:

• Influence hypothalamic hunger signaling

• Increase satiety responses

• Slow gastric emptying processes

• Affect reward-based feeding behavior

These findings are mechanistic and not therapeutic.

Metabolic Efficiency & Nutrient Partitioning (GIP)

GIP receptor activation is associated with energy utilization and metabolic balance.

Studies indicate Tirzepatide may:

• Improve metabolic flexibility

• Support nutrient utilization pathways

• Regulate energy storage mechanisms

• Enhance glucose-dependent insulin signaling

This dual action differentiates it from GLP-1–only compounds.

Glucose Metabolism & Insulin Signaling

Tirzepatide is widely studied in endocrine and metabolic research models.

Preclinical findings suggest it may:

• Support glucose-handling pathways

• Influence insulin sensitivity mechanisms

• Reduce hepatic glucose output

• Promote metabolic homeostasis

Body Composition Pathways (Research Context)

Due to its dual-receptor activity, Tirzepatide is also explored in research involving body composition.

Studies suggest it may:

• Support fat-oxidation pathways

• Influence adipose tissue regulation

• Improve nutrient partitioning

• Help preserve lean mass under controlled conditions

This is indirect and not a performance claim.

Cardiometabolic Research (Emerging)

Emerging areas of study include:

• Lipid-profile regulation

• Inflammatory signaling pathways

• Cardiometabolic system interactions

This area continues to develop.

 Frequently Paired With

• AOD-9604

• Retatrutide

• Metabolic Research Stack